The highly anticipated translations of the ECCO-EFCCA Patient Guidelines have been completed and will be officially  launched in February 2017 at the 12^th Congress of ECCO in Barcelona. The ECCO Guidelines on UC and CD are considered the reference for practice by a majority of the specialist IBD units in Europe. The translations of these guidelines from medical to lay language offers patients and physicians a common background of knowledge that may facilitate dialogue, understanding and common involvement in decision making.

Patient representatives participate in open debate on patient safety issues and right to information at the European Parliament

EFCCA CEO,  Luisa Avedano, participated at the press conference on Paediatric Digestive Health during the UEG Week in Vienna on 17 October 2016. She presented the Transition to Adult Care project that was being implemented by the EFCCA Youth Group and which aimed to better understand the needs of young people with IBD as concerns transitory care.

The press conference was organised following the publication of the UEG´s report on Paediatric Digestive Health Across Europe.

For more information please contact our offices.

By subscribing to our questionnaires, you agree with our policy for the treatment of your data.

Questionnaire BAB German language
 

Questionnaire BAB Spanish language
 

Questionnaire BAB Portoguese language
 

Questionnaire BAB Italian language
 

Nordic food branch Coop removes additives of concern from all new, own brand products
After call from the The Norwegian association for people with digestive diseases

Author: Marte Gylland Hegstad – web editor, Landsforeningen mot fordøyelsessykdommer (LMF)

EFCCA organised a symposium on “Digital Health and Data: IBD patients´ view and perspectives”  which took place during the ECCO Congress on 14 February 2020 from 14-15h in Vienna, Austria.

This was an unique event bringing together IBD patients, healthcare providers and other stakeholder in order to start discussions on how digital health and big data can contribute in delivering more personalised care and offering a higher quality of life of patients with IBD.

The pharmaceutical company, Pfizer, has launched a call for proposal within the framework of the "Independent Grants for Learning & Change".

The call is for proposals on "Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions".

Follow the link for more informatio:  https://www.pfizer.com/sites/default/files/rfp_files/IGLC_RFP_2018RA2_Im...

We launched our Youth Academy addressed to young IBD patients (aged between 18 and 30) with the aim to increase the representativeness of the youth group, create a cohesive group of leaders of tomorrow and to empower young representatives.

The training programme was launched in November 2021 via the EFCCA's online learning platform and was attended by 14 students.